drugset / Trial / NCT07457541
Molecular Imaging of Fibroblast Activation Protein Expression Using Labeled Technetium-99m HYNIC-FAPI
Phase 1
Active not recruiting
15 enrolled
Tomsk National Research Medical Center of the Russian Academy of Sciences
NaSingle-groupOpen-labelDiagnostic
Summary
The study should evaluate the biological distribution of 99mTc-HYNIC-FAPI in metastatic cancer patients.
Timeline
- Start
- 2026-02-26
- Primary completion
- 2026-12-31
- Completion
- 2027-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | [99mTc]Tc-HYNIC-FAPI | Diagnostic / imaging agent | — | Intravenous |